NO20005079L - Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser - Google Patents

Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser

Info

Publication number
NO20005079L
NO20005079L NO20005079A NO20005079A NO20005079L NO 20005079 L NO20005079 L NO 20005079L NO 20005079 A NO20005079 A NO 20005079A NO 20005079 A NO20005079 A NO 20005079A NO 20005079 L NO20005079 L NO 20005079L
Authority
NO
Norway
Prior art keywords
collagen
native
liquid medium
sterilizing
same
Prior art date
Application number
NO20005079A
Other languages
English (en)
Other versions
NO20005079D0 (no
Inventor
Hamza Mansour
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20005079D0 publication Critical patent/NO20005079D0/no
Publication of NO20005079L publication Critical patent/NO20005079L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20005079A 1998-04-10 2000-10-09 Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser NO20005079L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804531A FR2777284B1 (fr) 1998-04-10 1998-04-10 Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications
PCT/FR1999/000814 WO1999052946A1 (fr) 1998-04-10 1999-04-09 Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications

Publications (2)

Publication Number Publication Date
NO20005079D0 NO20005079D0 (no) 2000-10-09
NO20005079L true NO20005079L (no) 2000-12-08

Family

ID=9525129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005079A NO20005079L (no) 1998-04-10 2000-10-09 Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser

Country Status (20)

Country Link
EP (1) EP1068240B1 (no)
JP (1) JP2002511489A (no)
KR (1) KR20010042539A (no)
CN (1) CN1304416A (no)
AT (1) ATE229982T1 (no)
AU (1) AU3151499A (no)
BR (1) BR9909566A (no)
CA (1) CA2327882A1 (no)
DE (1) DE69904578T2 (no)
EE (1) EE200000592A (no)
FR (1) FR2777284B1 (no)
HU (1) HUP0102575A2 (no)
ID (1) ID26038A (no)
IL (1) IL138562A0 (no)
NO (1) NO20005079L (no)
PL (1) PL343523A1 (no)
RU (1) RU2188206C2 (no)
WO (1) WO1999052946A1 (no)
YU (1) YU61100A (no)
ZA (1) ZA200005497B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
AT411326B (de) * 2000-06-20 2003-12-29 Biering Wolfgang Hämostatische collagen-pellets
RU2220724C1 (ru) * 2002-11-20 2004-01-10 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Антимикробное и ранозаживляющее средство "ультракол"
CA2554994C (en) * 2004-01-30 2015-05-19 Ferrosan A/S Haemostatic sprays and compositions
JP4705359B2 (ja) * 2004-10-20 2011-06-22 新田ゼラチン株式会社 鳥類由来コラーゲンを用いてなる化粧料組成物
DE102005017845A1 (de) 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptische Kollagenzubereitungen, ihre Verwendung und Verfahren zu ihrer Herstellung
CN101332316B (zh) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 生物型鼻梁植入体
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
JP5632162B2 (ja) * 2007-06-01 2014-11-26 協和発酵バイオ株式会社 経口組成物
RU2433828C1 (ru) * 2010-10-14 2011-11-20 Закрытое акционерное общество "БИОМИР сервис" Инъекционный гетерогенный биополимерный гидрогель для заместительной и регенеративной хирургии и способ его получения
TWI552774B (zh) * 2011-05-24 2016-10-11 武田公司 經輥軋之膠原蛋白載體
JP6242874B2 (ja) 2012-05-24 2017-12-06 タケダ エイエスＴａｋｅｄａ ＡＳ パッケージ
BR112014028594B1 (pt) 2012-05-24 2021-11-30 Takeda As Aparelho para prover um carregador de colágeno enrolado e processo para enrolar um carregador de colágeno
CN102846536B (zh) * 2012-09-26 2014-03-26 关节动力安达（天津）生物科技有限公司 一种含有i型胶原蛋白的精华液
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
WO2019208831A1 (ja) * 2018-04-27 2019-10-31 凸版印刷株式会社 細胞外マトリックス含有組成物、三次元組織体形成用仮足場材及び三次元組織体形成剤並びに三次元組織体から細胞を回収する方法
RU2715715C1 (ru) * 2019-03-06 2020-03-03 Общество с ограниченной ответственностью фирмы "Имтек" Стерильный прозрачный концентрированный раствор биосовместимого коллагена, способ его получения и применения
CN110354246A (zh) * 2019-07-22 2019-10-22 中肽生物科技(大连)有限公司 一种纳米级小分子复合肽养眼液的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2462222A1 (de) * 1974-02-02 1976-05-06 Trommsdorff Fa H Loesliches, natives human-kollagen, dessen nicht-helikale peptide teilweise oder vollstaendig abgetrennt sind
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
DE3522626A1 (de) * 1985-06-25 1987-01-08 Merz & Co Gmbh & Co Loeslicher kollagen-schwamm
FR2586703B1 (fr) * 1985-09-02 1989-12-01 Merieux Inst Procede d'extraction de collagenes placentaires, collagenes obtenus notamment sous forme de gels ou de solutions et leurs applications
IT1181737B (it) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Supproto di collagene biologicamente attivo per uso cosmetico e farmaceutico e metodo per prepararlo
GB8812992D0 (en) * 1988-06-01 1988-07-06 Natural Resources Mfg Ltd Improvements in/relating to protein products
RU2076718C1 (ru) * 1993-04-09 1997-04-10 Курский Государственный Медицинский Институт Способ получения коллагена
FR2715309B1 (fr) * 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
CA2146090C (en) * 1994-05-10 1998-11-24 Mark E. Mitchell Apparatus and method of mixing materials in a sterile environment
RU2116801C1 (ru) * 1995-06-15 1998-08-10 Институт элементоорганических соединений РАН Способ получения пористого коллагенсодержащего материала
US5670369A (en) * 1996-06-25 1997-09-23 Ranpak Corporation Method for the production of soluble collagen

Also Published As

Publication number Publication date
AU3151499A (en) 1999-11-01
ATE229982T1 (de) 2003-01-15
CN1304416A (zh) 2001-07-18
YU61100A (sh) 2003-10-31
PL343523A1 (en) 2001-08-27
ID26038A (id) 2000-11-16
EP1068240A1 (fr) 2001-01-17
CA2327882A1 (en) 1999-10-21
KR20010042539A (ko) 2001-05-25
WO1999052946A1 (fr) 1999-10-21
ZA200005497B (en) 2001-04-24
BR9909566A (pt) 2000-12-26
EP1068240B1 (fr) 2002-12-18
DE69904578T2 (de) 2003-11-20
FR2777284B1 (fr) 2000-05-26
HUP0102575A2 (hu) 2001-11-28
DE69904578D1 (de) 2003-01-30
JP2002511489A (ja) 2002-04-16
EE200000592A (et) 2002-04-15
NO20005079D0 (no) 2000-10-09
IL138562A0 (en) 2001-10-31
RU2188206C2 (ru) 2002-08-27
FR2777284A1 (fr) 1999-10-15

Similar Documents

Publication Publication Date Title
NO20005079L (no) Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser
IS6817A (is) Dauðhreinsun lyfja
DE69321538D1 (de) Wässrige Dispersionen von Zein und Beschichtungen mit gesteuerter Freisetzung
CA2247860A1 (en) Method for treating liquid materials
DE69432832D1 (de) Vorrichtung und verfahren zur photoaktivierung
ES2032121T3 (es) Particulas de emulsion gelificadas y composiciones que las contienen.
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
BR9707888A (pt) Meio de conservação e/ou de congelamento de material biológico, composição e processo de armazenagem de material biológico
DK0691858T3 (da) Tokomponent fibrinklæber
DE602004016342D1 (de) Sterilisiersystem
ES2058117T3 (es) Composicion esterilizante liquida.
ES2114322T3 (es) Fluido de dialisis que contiene peptidos obtenidos de caseina como agentes osmoticos, e iones bicarbonato como agentes tamponadores.
ATE305295T1 (de) Vorrichtung zur freigabe von stoffen
ES2073700T3 (es) Composicion que contiene un polisacarido obtenido por fermentacion microbiana.
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
ATE209647T1 (de) Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
MY124594A (en) Method of manufacturing an aseptic coagulated food product
BR0014058A (pt) Produto sólido, composição, solução aquosa de 4,4-dimetil-5a-colesta-8,14,24-triene-3(beta) -ol, e, dispositivo tendo uma concavidade
ATE225653T1 (de) Neomycin/disaccharid wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie
Yamamoto et al. Inhibitory Effect of Lead on the Release of Tissue Plasminogen Activator from Human Vascular Endothelial Cells in Culture (Proceedings of the 18th Symposium on Toxicology, and Environmental Health)
KR970019821A (ko) 송진을 함유한 치약 제조 방법
DE3761283D1 (de) Zusammensetzungen zur desinfektion und zur sterilisation.
KR970042591A (ko) 트레할로스를 안정제로 이용한 단백질용액의 액상가열처리방법
Tsuji et al. An Application of Fuzzy System to Orthodontic Diagnosis in Orthosurgical Case
Kaji et al. Remodeling of Vascular Endothelial Glycocalyx by Basic Fibroblast Growth Factor (Proceedings of the 23rd Symposium on Toxicology and Environmental Health)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application